Boston, MA (PRWEB) December 24, 2008
Neuroblastoma is certainly no laughing matter. It is the most common form of cancer diagnosed in infants. However, on January 9, 2009, some of Boston's finest will come together at the Cutler Majestic Theater for "Comics for a Cure," http://www.comicsforacure.org, to bring much needed attention to this aggressive form of pediatric cancer. The evening's impressive comedic lineup includes event host Joe List, Nick DiPaolo, Gary Gulman, Kevin Knox and Kelly MacFarland. Event proceeds will benefit the Children's Neuroblastoma Cancer Foundation, http://www.nbhope.org, an organization dedicated to funding research and clinical trials as well as educating and supporting families who have been affected by this deadly disease.
"Comics for a Cure" was conceived by Tracy Harding, a Boston resident whose niece was diagnosed with Neuroblastoma when she was two months old. Now one, her niece continues her courageous battle with the deadly disease.
"I can't even begin to understand what the journey is like for all parents of children with pediatric cancer, or for the children, survivors and angels of this disease -- I won't pretend that I do," stresses Harding. "I created this event for them, as well as the amazing nurses, doctors, hospice workers, etc. that made the choice to work with these children. My hope is that 'Comics for a Cure' will raise awareness, much needed funds and be an awesome night of comedy for this very deserving group."
Tickets for "Comics for a Cure" are on sale now through http://www.comicsforacure.org or by calling Telecharge at 800-233-3123. Consider donating tickets for local families affected by the disease. Sponsors for this one-of-a-kind event are still needed! For more information and complete sponsorship details, please visit the event Website or send an email to info at comicsforacure dot org.
Neuroblastoma is a solid tumor cancer that arises in immature nerve cells and most often strikes infants and toddlers. Its cause is unknown. Nearly 70 percent of children diagnosed with Neuroblastoma have advanced stage disease; less than 30 percent of those children live five years. Today, less than one percent of the federal cancer research budget goes toward Neuroblastoma and survival rates have not improved significantly in the past 20 years.
Be aware. Be an advocate. A child's life depends on it. For more information, visit: http://www.nbhope.org.
# # #